• Ipsat Therapies Oy
    • Viikinkaari 4, FI-00790
    • Helsinki, Finland

Background facts

  • up to 80% of hospital infections originate from gut bacteria
  • severe forms of antibiotic-induced diarrhea may be fatal and have considerable economic consequences, as well as spread disease
  • infections due to antibiotic-induced resistance may be fatal in patients with compromised immunity or the elderly (post-operative, HIV and cancer)

Medical scope of the IPSAT™ technology

  • antibiotic-induced bacterial resistance
  • hospital infections, especially by resistant strains
  • antibiotic-induced colitis
  • antibiotic-induced diarrhea

Benefits of IPSAT™

  • reduction in the number of multiresistant bacteria
  • reduction in hospital infections, especially in elderly, immunocompromised and HIV patients
  • reduce hospital stay + lower treatment costs